Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Veracyte (VCYT) Inventory (2016 - 2025)

Veracyte's Inventory history spans 14 years, with the latest figure at $20.3 million for Q3 2025.

  • For Q3 2025, Inventory changed 0.18% year-over-year to $20.3 million; the TTM value through Sep 2025 reached $20.3 million, changed 0.18%, while the annual FY2024 figure was $21.8 million, 34.86% up from the prior year.
  • Inventory for Q3 2025 was $20.3 million at Veracyte, down from $25.0 million in the prior quarter.
  • Across five years, Inventory topped out at $25.0 million in Q2 2025 and bottomed at $6.3 million in Q1 2021.
  • The 5-year median for Inventory is $14.3 million (2022), against an average of $14.8 million.
  • The largest annual shift saw Inventory soared 141.04% in 2021 before it decreased 20.74% in 2023.
  • A 5-year view of Inventory shows it stood at $11.2 million in 2021, then rose by 27.34% to $14.3 million in 2022, then grew by 12.83% to $16.1 million in 2023, then surged by 34.86% to $21.8 million in 2024, then fell by 6.54% to $20.3 million in 2025.
  • Per Business Quant, the three most recent readings for VCYT's Inventory are $20.3 million (Q3 2025), $25.0 million (Q2 2025), and $21.8 million (Q4 2024).